Lifetime Cost Effectiveness of Phenylketonuria Screening Na-tional Program in Iran
Background: Phenylketonuria (PKU) is an autosomal recessive disorder that screening and timely control of this disorder can prevent the adverse effects. Regarding the high prevalence of PKU in Iran, the PKU screening program was started in Iran in 2006. This study was conducted to determine the cos...
Saved in:
Main Authors: | Alireza Heidari, Mohammad Arab, Behzad Damari |
---|---|
Format: | article |
Language: | EN |
Published: |
Tehran University of Medical Sciences
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/d329c8e167cc4ad4ba25f7b96aa5bc6a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Updated <i>PAH</i> Mutational Spectrum of Phenylketonuria in Mexican Patients Attending a Single Center: Biochemical, Clinical-Genotyping Correlations
by: Marcela Vela-Amieva, et al.
Published: (2021) -
Evaluation of Nutritional Status and Growth in Phenylketonuria Patients in Mazandaran Province Iran
by: Eshraghi P, Abbaskhanian A, Bijani A, Hosseinzadeh S
Published: (2011) -
Improving phenylalanine and micronutrients status of children with phenylketonuria: a pilot randomized study
by: Reza Zamani, et al.
Published: (2021) -
Telehealth and COVID-19: Empowering Standards of Management for Patients Affected by Phenylketonuria and Hyperphenylalaninemia
by: Valentina Rovelli, et al.
Published: (2021) -
Italian national consensus statement on management and pharmacological treatment of phenylketonuria
by: Alberto Burlina, et al.
Published: (2021)